Cases & Deals

  • Home
  • Practices
  • Isis Pharmaceuticals builds patent portfolio for certain clinical development compounds

Share

Isis Pharmaceuticals builds patent portfolio for certain clinical development compounds

January 2008

Client(s) Isis Pharmaceuticals, Inc.

On behalf of Isis Pharmaceuticals, Inc., Jones Day assisted with patent prosecution strategy and portfolio development concerning some of its clinical development compounds.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.